Gelteq Limited Ordinary Shares(GELS)

Drug Manufacturers - Specialty & Generic · Clayton, VIC

$0.56+0.02 (+3.60%)

Delayed quote: Oct 6, 2026, 10:46 AM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T14:57:03.209Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:57:03.209Z.

Quote observation: 2026-10-06T14:46:31.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,170,576
TTM free cash flow · period ending 2024-06-30: N/A

FMP input reference: 6ebeba272bae7de15d59b23151f0025007a9c632b25eeddd13cd9ab927e6ebe5

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

GELS Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

GELS Competitors' Price/FCF Ratio

GELS

Gelteq Limited Ordinary Shares

Current

Market Cap

$5.17M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LNAI

Lunai Bioworks Inc.

vs GELS

Market Cap

$5.19M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LIMN

Liminatus Pharma, Inc. Class A Common Stock

vs GELS

Market Cap

$5.21M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs GELS

Market Cap

$5.27M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMGL

Basel Medical Group Ltd Ordinary Shares

vs GELS

Market Cap

$5.01M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMNN

Imunon, Inc.

vs GELS

Market Cap

$5.04M

Price/FCF Ratio

N/A

TTM Avg

15.88

3Y Avg

17.94

5Y Avg

17.94

ALZN

Alzamend Neuro Inc

vs GELS

Market Cap

$5.36M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs GELS

Market Cap

$4.83M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs GELS

Market Cap

$5.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs GELS

Market Cap

$4.78M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Gelteq Limited Ordinary Shares (GELS)	$5.17M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.19M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.27M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.01M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.04M	N/A	15.88	17.94	17.94
Alzamend Neuro Inc (ALZN)vs ›	$5.36M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.83M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.54M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$4.78M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

GELS Price/FCF Ratio Metrics

GELS Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics